drugset / Trial / NCT01295034
Vitamin D Supplements for HIV-positive Patients on cART
RandomizedParallel-groupDouble-blindTreatment
Summary
The ability of vitamin D to modulate the immune system and strengthen bones may mitigate the adverse medication consequences of HIV/AIDS, but little is known about either the health benefits of vitamin D supplements, or about the optimal dosing regimen for patients on highly active antiretroviral therapy (HAART). This trial is a comparison of two regimens for administering vitamin D and calcium to HIV-positive individuals taking antiviral medications. This study will help physicians make evidence-based decisions about the most effective way to use vitamin D in their patients and enable the design of large multi-center trials in the future.
Timeline
- Start
- 2011-03
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 1000 iu | Oral |
| Subject | Cholecalciferol | Other / unclassified | 2000 iu | Oral |
| Subject | Cholecalciferol | Other / unclassified | 4000 iu | Oral |
| Subject | Ergocalciferol | Small molecule | 50000 iu | Oral |